Case Details
- Citation: [2017] SGCA 68
- Case Number: Civil Appeal Nos 160 of 2016 and 47 of 2017
- Date of Decision: 01 December 2017
- Court: Court of Appeal of the Republic of Singapore
- Coram: Sundaresh Menon CJ; Tay Yong Kwang JA; Steven Chong JA
- Judgment Author: Steven Chong JA (delivering the judgment of the court)
- Parties: Centre for Laser and Aesthetic Medicine Pte Ltd (appellant in CA 160/2016; respondent in CA 47/2017) v GPK Clinic (Orchard) Pte Ltd and others (respondents in CA 160/2016; appellants in CA 47/2017)
- Defendants/Respondents (as described): GPK Clinic (Orchard) Pte Ltd; Goh Pui Kiat; Wong Hwee Leng
- Procedural History: Appeal from the High Court decision in Centre for Laser and Aesthetic Medicine Pte Ltd v Goh Pui Kiat and others [2017] SGHC 72
- Legal Areas: Civil Procedure — Costs; Contract — Contractual terms (express terms and interpretation); Equity — Fiduciary relationships; Tort — Confidence; Tort — Conspiracy (unlawful means conspiracy)
- Statutes Referenced: Medical Registration Act
- Cases Cited: [2017] SGCA 68 (self-referential in metadata); [2017] SGHC 72
- Judgment Length: 25 pages, 13,865 words
- Counsel: Thio Shen Yi SC, Wee Yu Ping Nicole, Ngo Shuxiang Nicholas and Goh Qian En Benjamin (TSMP Law Corporation) for the appellant in Civil Appeal No 160 of 2016 and the respondent in Civil Appeal No 47 of 2017; Pereira George Barnabas (Pereira & Tan LLC) for the respondents in Civil Appeal No 160 of 2016 and the appellants in Civil Appeal No 47 of 2017
Summary
In Centre for Laser and Aesthetic Medicine Pte Ltd v GPK Clinic (Orchard) Pte Ltd and others and another appeal [2017] SGCA 68, the Court of Appeal addressed how to interpret a settlement agreement that contained seemingly conflicting provisions: one clause required the doctors to continue fulfilling their responsibilities to the clinics pending sale, while another clause permitted them to set up competing clinics and simultaneously barred them from making allegations or claims about diversion of patients/customers. The dispute arose after one doctor set up a competing clinic nearby, copied the other clinic’s patient and inventory database without authorisation, and actively diverted patients using confidential information.
The High Court had found liability for breach of confidence and for conspiracy to injure, but dismissed CLAM’s claims relating to patient diversion on the basis that the settlement agreement expressly permitted diversion. On appeal, CLAM argued that the “no allegations/no claims” clause could not be construed to permit active diversion with impunity, because such a reading would undermine the settlement’s commercial purpose and would allow the doctors to “harm” CLAM notwithstanding fiduciary duties. The Court of Appeal’s analysis focused on reconciling the agreement’s clauses as a whole and on whether the contractual permission extended to conduct that would otherwise breach equitable duties.
What Were the Facts of This Case?
The underlying relationship was one of co-operation and shared professional practice, but it was also structured around competing duties and shared ownership. Dr Kelvin Goh and Dr Goh Pui Kiat (“Dr Goh PK”) worked at the Orchard Clinic on different days, such that one of them would be on duty at any given time. The Orchard Clinic was owned by Centre for Laser and Aesthetic Medicine Pte Ltd (“CLAM”), which was in turn owned in equal shares by the doctors’ wives. CLAM’s registered directors were the wives, while the doctors were de facto directors. Both doctors and their respective spouses were therefore closely intertwined in the governance and operation of CLAM.
In addition to the Orchard Clinic, the doctors co-owned another aesthetic clinic, 8-11 Clinic & Surgery, through Medical Practice Consultants Pte Ltd (“MPC”). Both clinics focused on providing aesthetic treatments. The dispute that led to the settlement began when Dr Goh PK commenced Suit No 1023 of 2013 against Dr Kelvin Goh. In that suit, Dr Goh PK alleged, among other things, that Dr Kelvin Goh had diverted the business of the clinics to his own business, SkintechMD Pte Ltd, which sold similar products online.
To resolve that dispute, the doctors and their wives entered into a settlement agreement on 14 February 2014 following mediation. The agreement was, in substance, an exit arrangement. The parties agreed to procure the sale of the clinics (and related companies) by 31 December 2016 at a minimum price of $6m, failing which a closed auction between the parties would take place in January 2017. Importantly, pending sale, the doctors were required to continue fulfilling their responsibilities to the clinics on their assigned days. At the same time, the agreement recognised that the parties were parting ways and permitted each doctor to set up competing clinics in the interim.
The agreement also contained a further provision designed to prevent renewed litigation about patient diversion. Clause 10 (as described in the judgment extract) provided that the parties were “entirely at liberty” to set up other businesses or clinics in Singapore, and that “none of the Parties shall make any allegations or make any claim in respect of diversion of patients/customers” from the companies. After the agreement, Dr Goh PK set up GPK Clinic (Orchard) Pte Ltd (“GPK Clinic”) two units away from the Orchard Clinic and began operations on 19 May 2014. Although the agreement permitted competing clinics, Dr Goh PK also diverted patients from the Orchard Clinic to GPK Clinic, and he did so while working on his assigned days at the Orchard Clinic. More seriously, he copied CLAM’s patient and inventory database without permission and used confidential information from that database to divert patients.
What Were the Key Legal Issues?
The principal legal issue on appeal concerned contractual interpretation in the presence of clauses that could appear to conflict. The Court of Appeal had to decide whether the settlement agreement’s “no allegations/no claims” clause about diversion of patients/customers permitted the doctors to actively divert patients to their new clinics with impunity, even where such diversion would otherwise breach fiduciary duties owed to CLAM. Put differently, the question was whether the contractual permission extended to conduct that would “harm” CLAM, notwithstanding equitable obligations.
A related issue concerned the interaction between contractual terms and equitable duties. The defendants accepted that their submission would mean the parties “did not owe the same duties to CLAM as they did prior to the [Agreement]” and that they could harm CLAM by competing against it. The Court therefore had to determine the proper scope of any contractual modification or waiver of duties, and whether the agreement could be construed to authorise conduct that would otherwise be wrongful as a matter of equity and confidence.
Finally, the appeal also engaged civil procedure and costs. The defendants’ appeal was limited to the costs order. The Court of Appeal therefore had to consider whether the High Court’s approach to costs allocation and recovery of expert and party-and-party costs was correct in light of the outcome below.
How Did the Court Analyse the Issues?
The Court of Appeal began by framing the interpretive challenge: agreements sometimes contain clauses that seem to conflict, and the court must decide how to reconcile them so that the agreement is construed as a whole. The judgment emphasised that where giving effect to one clause would defeat or emasculate the substance of another, the court must adopt a construction that preserves the agreement’s overall commercial purpose. This approach is consistent with established principles of contract interpretation, but the Court highlighted the need for careful reconciliation rather than literal reading of isolated provisions.
In this case, the Court treated the settlement agreement as an exit arrangement with a controlled transition. Clause 7 required the doctors to continue fulfilling their responsibilities to the clinics pending sale. Clause 10 permitted the doctors to set up competing clinics and barred allegations or claims about diversion of patients/customers. The Court recognised that these provisions could generate tension: allowing competition while requiring continued responsibilities, and simultaneously preventing claims about diversion, could be read in a way that undermines the intended orderly disengagement.
CLAM’s argument was that the “no allegations/no claims” clause could not be read to permit active diversion using confidential information or in a manner that would deplete CLAM’s patient base and thereby defeat the agreement’s purpose of facilitating a sale at a minimum price. The Court accepted that the agreement’s commercial context mattered. The settlement was designed to manage the parties’ parting ways over almost three years, culminating in a sale at a minimum price of $6m. A construction that allowed one doctor to undermine that value by actively diverting patients would, in practical effect, frustrate the agreement’s core objective.
On the other hand, the defendants argued that diversion of patients was inherent in competition, and that clause 10 therefore permitted diversion. The Court’s analysis addressed the key limitation: even if competition was permitted, the agreement could not reasonably be construed to authorise wrongful conduct that would breach fiduciary duties and confidentiality. The Court’s reasoning turned on the pivotal inquiry identified in the judgment extract: whether the agreement’s terms permitted the parties to “harm” CLAM notwithstanding their fiduciary duties to CLAM. This is a crucial doctrinal point because it prevents parties from using contractual drafting to immunise conduct that would otherwise be inequitable or unlawful.
The Court also considered the utility of subjective understanding and subsequent conduct in interpreting the agreement. The extract indicates that the Court examined whether such evidence could assist in deriving the proper construction. However, the Court’s approach suggests that subjective understanding and subsequent conduct are not a substitute for objective interpretation of the contract’s text and structure. Instead, they may have limited utility where the language remains ambiguous or where they help confirm the construction that best reconciles the clauses and preserves the agreement’s purpose.
Although the High Court had already found breach of confidence and conspiracy to injure in relation to the unauthorised copying of the database, the appellate dispute focused on whether the patient diversion claims should have been dismissed. The Court’s analysis therefore had to ensure that contractual interpretation did not create an incoherent result: the defendants were liable for using confidential information, yet the agreement was said to permit diversion. The Court’s reasoning, as reflected in the framing of the interpretive tension, sought to avoid a construction that would effectively allow the same wrongful conduct to be characterised as contractually permitted simply because it resulted in diversion.
On costs, the Court of Appeal would have reviewed the High Court’s costs allocation methodology. The High Court had made a nuanced costs order: CLAM was entitled to recover 40% of its costs (inclusive of expert fees), and party-and-party costs paid by Dr Goh PK and GPKPL to CLAM were to be applied to CLAM’s outstanding solicitor-and-client costs obligations, with any balance reimbursing Dr Kelvin Goh for costs he had paid on behalf of CLAM. The defendants’ limited appeal on costs required the Court to consider whether the percentage recovery and the allocation mechanism were appropriate given the partial success of the parties’ claims.
What Was the Outcome?
The Court of Appeal dismissed the defendants’ appeal against the costs order and upheld the High Court’s approach to costs recovery. Practically, this meant that CLAM continued to recover only a portion of its costs, reflecting that it had succeeded on some claims (breach of confidence and conspiracy to injure) but failed on others, including the diversion-of-patients claims as framed at first instance.
More broadly, the Court of Appeal’s decision clarified that contractual clauses permitting competition and barring claims about diversion cannot be read in isolation to authorise conduct that would otherwise breach fiduciary duties and equitable obligations. The outcome therefore reinforces that settlement agreements must be interpreted to preserve their overall commercial purpose and that courts will resist constructions that would permit “harm” to the protected party under the guise of contractual permission.
Why Does This Case Matter?
This decision is significant for practitioners because it illustrates how Singapore courts approach the interpretation of settlement agreements containing clauses that may appear to conflict. The Court of Appeal’s emphasis on construing the agreement as a whole, reconciling discordant clauses, and preserving the agreement’s substance provides a useful framework for drafting and litigating commercial settlements. Parties negotiating exit arrangements, non-competition-like compromises, or transitional operational clauses should expect courts to look beyond literal wording and to consider how the clauses function together.
Equally important is the Court’s treatment of the relationship between contract and fiduciary duties. Even where an agreement permits competition, the court will scrutinise whether the permission extends to conduct that would otherwise be wrongful in equity. This is particularly relevant in professional or quasi-fiduciary contexts, including medical and aesthetic practices where confidentiality, patient relationships, and fiduciary obligations often overlap with commercial arrangements. The case signals that contractual drafting cannot easily be used to immunise misuse of confidential information or conduct that undermines the protected party’s legitimate interests.
For litigators, the case also demonstrates the evidential and remedial consequences of partial success. Costs outcomes can be sensitive to how claims are characterised and which causes of action succeed. The High Court’s detailed costs mechanism, and the Court of Appeal’s refusal to disturb it, show that courts may calibrate costs recovery to reflect the proportionate success of the parties’ claims.
Legislation Referenced
- Medical Registration Act
Cases Cited
- [2017] SGCA 68
- [2017] SGHC 72
Source Documents
This article analyses [2017] SGCA 68 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.